Grupo de investigación en enfermedades raras respiratorias
ERR
GlaxoSmithKline (United Kingdom)
Londres, Reino UnidoPublicacións en colaboración con investigadores/as de GlaxoSmithKline (United Kingdom) (5)
2024
-
Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial
Archivos de Bronconeumologia, Vol. 60, Núm. 7, pp. 417-422
2022
-
Cost-Effectiveness of Once-Daily Single-Inhaler COPD Triple Therapy in Spain: IMPACT Trial
International journal of chronic obstructive pulmonary disease, Vol. 17, pp. 3097-3109
2020
-
Cost-effectiveness analysis of a once-daily single-inhaler triple therapy for patients with chronic obstructive pulmonary disease (COPD) using the fulfil trial: A Spanish perspective
International Journal of COPD, Vol. 15, pp. 1621-1632
2018
-
Bacteria from bronchoalveolar lavage fluid from children with suspected chronic lower respiratory tract infection: results from a multi-center, cross-sectional study in Spain
European Journal of Pediatrics, Vol. 177, Núm. 2, pp. 181-192
2012
-
Patient-centred assessment of COPD in primary care: experience from a cross-sectional study of health-related quality of life in Europe
PRIMARY CARE RESPIRATORY JOURNAL, Vol. 21, Núm. 3, pp. 329-336